Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors (Q33299912)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors
scientific article

    Statements

    Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors (English)
    Jinjiang Zhu
    Michael D Johnson
    Jill Kornmann
    Alessandra Blasina
    James Register
    Kenna Anderes
    Caroline Rogers
    Sacha Ninkovic
    Stephan Grant
    Karen Lundgren
    Zhengwei Peng
    Robert S Kania
    21 September 2007
    5253-5256

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit